Joaquín Borrás-Blasco

Summary

Publications

  1. doi request reprint Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients
    Joaquín Borrás-Blasco
    Specialist in Hospital Pharmacy, Hospital de Sagunto, Pharmacy Service, Avda Ramon y Cajal s n, Sagunto, E 46520, Spain
    Expert Opin Biol Ther 14:145-50. 2014
  2. doi request reprint Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen
    Joaquín Borrás-Blasco
    Hospital de Sagunto, Pharmacy Department, Avda Ramon y Cajal s n, Sagunto, E 46520, Spain
    Expert Opin Biol Ther 13:1103-8. 2013
  3. doi request reprint Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen
    Joaquín Borrás-Blasco
    Hospital de Sagunto, Pharmacy Department, Avda Ramon y Cajal s n, Sagunto, Valencia, Spain
    Expert Opin Biol Ther 10:301-7. 2010
  4. doi request reprint Adverse cutaneous reactions induced by TNF-alpha antagonist therapy
    Joaquín Borrás-Blasco
    Pharmacy Department, Hospital de Sagunto, Sagunto, Spain
    South Med J 102:1133-40. 2009
  5. doi request reprint Urticaria due to etanercept in a patient with psoriatic arthritis
    Joaquín Borrás-Blasco
    Pharmacy Service and Rehabilitation Section, Hospital de Sagunto, Sagunto, Spain
    South Med J 102:304-5. 2009
  6. doi request reprint Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab
    J Borras-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    J Clin Pharm Ther 33:321-5. 2008
  7. doi request reprint Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection
    J Borras-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Spain
    J Antimicrob Chemother 62:879-88. 2008
  8. ncbi request reprint Parapharyngeal abscess in a patient receiving etanercept
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    Ann Pharmacother 41:341-4. 2007
  9. doi request reprint Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient
    Joaquín Borrás-Blasco
    Pharmacy Service, The Gastroenterology Section, Hospital de Sagunto, Valencia, Spain
    South Med J 101:88-90. 2008
  10. ncbi request reprint Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Ann Pharmacother 37:1241-3. 2003

Collaborators

  • Rafael Alos
  • Joaquin Hinojosa
  • J Dolores Rosique-Robles
  • Md Elvira Casterá
  • Antonio Galán Brotons
  • Nuria Maroto
  • José María Vicent Verge

Detail Information

Publications16

  1. doi request reprint Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients
    Joaquín Borrás-Blasco
    Specialist in Hospital Pharmacy, Hospital de Sagunto, Pharmacy Service, Avda Ramon y Cajal s n, Sagunto, E 46520, Spain
    Expert Opin Biol Ther 14:145-50. 2014
    ..At a time when the cost of therapy is an unavoidable component of healthcare treatment decisions, ETN25 could be a cost-effective option for selective RA, PA and AS patients. ..
  2. doi request reprint Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen
    Joaquín Borrás-Blasco
    Hospital de Sagunto, Pharmacy Department, Avda Ramon y Cajal s n, Sagunto, E 46520, Spain
    Expert Opin Biol Ther 13:1103-8. 2013
    ..To assess patients' acceptability of switching etanercept from the prefilled syringe to the autoinjection pen in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis patients...
  3. doi request reprint Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen
    Joaquín Borrás-Blasco
    Hospital de Sagunto, Pharmacy Department, Avda Ramon y Cajal s n, Sagunto, Valencia, Spain
    Expert Opin Biol Ther 10:301-7. 2010
    ..To assess patients' acceptance of switching adalimumab from a prefilled syringe to an autoinjection pen...
  4. doi request reprint Adverse cutaneous reactions induced by TNF-alpha antagonist therapy
    Joaquín Borrás-Blasco
    Pharmacy Department, Hospital de Sagunto, Sagunto, Spain
    South Med J 102:1133-40. 2009
    ..To review adverse cutaneous drug reactions induced by tumor necrosis factor alpha (TNF-alpha) antagonist therapy...
  5. doi request reprint Urticaria due to etanercept in a patient with psoriatic arthritis
    Joaquín Borrás-Blasco
    Pharmacy Service and Rehabilitation Section, Hospital de Sagunto, Sagunto, Spain
    South Med J 102:304-5. 2009
    ..The adverse reaction could be considered probable. Although the overall risk of skin adverse events associated with etanercept appears low, clinicians should be aware of this reaction...
  6. doi request reprint Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab
    J Borras-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    J Clin Pharm Ther 33:321-5. 2008
    ..To report a case of a patient with psoriatic arthritis (PsA) receiving adalimumab, who developed an exacerbation of palmoplantaris pustulosa psoriasis...
  7. doi request reprint Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection
    J Borras-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Spain
    J Antimicrob Chemother 62:879-88. 2008
    ....
  8. ncbi request reprint Parapharyngeal abscess in a patient receiving etanercept
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Sagunto, Valencia, Spain
    Ann Pharmacother 41:341-4. 2007
    ..To report a case of parapharyngeal abscess associated with Streptococcus viridans in a patient with rheumatoid arthritis receiving treatment with etanercept...
  9. doi request reprint Severe stomatitis complicating treatment with pegylated-interferon alpha-2a and ribavirin in an HCV-infected patient
    Joaquín Borrás-Blasco
    Pharmacy Service, The Gastroenterology Section, Hospital de Sagunto, Valencia, Spain
    South Med J 101:88-90. 2008
    ..To report a case of severe stomatitis probably induced by peginterferon alpha-2a...
  10. ncbi request reprint Photo-induced Stevens-Johnson syndrome due to sulfasalazine therapy
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Ann Pharmacother 37:1241-3. 2003
    ..To report a case of photo-induced Stevens-Johnson Syndrome (SJS) due to sulfasalazine therapy...
  11. ncbi request reprint Hair loss induced by lopinavir-ritonavir
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital de Sagunto, Valencia, Spain
    Pharmacotherapy 27:1215-8. 2007
    ..If alopecia is severe or particularly distressing to the patient, the offending drug should be discontinued, and therapy with another HIV drug should be started...
  12. doi request reprint Severe myalgia associated with adalimumab treatment in a patient with Crohn's disease
    Joaquin Hinojosa
    Gastroenterology Unit, Coloproctology Clinic, Hospital de Sagunto, Sagunto, Valencia, Spain
    Ann Pharmacother 42:1130-3. 2008
    ..To report a case of severe myalgia associated with adalimumab in a patient with Crohn's disease...
  13. ncbi request reprint Generalised erythematous skin eruptions induced by sorafenib: cutaneous toxicity and treatment outcome
    Antonio Galán Brotons
    Oncology Service, Hospital de Sagunto, Universidad de Valencia, Valencia, Spain
    Clin Transl Oncol 10:844-6. 2008
    ..This therapeutic efficacy of EGFR inhibitors and cutaneous side effects should be better assessed in large cohorts or trials to determine whether the skin toxicity of patients can be linked to an objective antitumour response...
  14. ncbi request reprint Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Spain
    Am J Med Sci 330:144-6. 2005
    ..Levofloxacin therapy could be a therapeutic alternative, although pharmacokinetic/pharmacodynamic studies should be conducted...
  15. ncbi request reprint Acenocoumarol-induced Henoch-Schönlein purpura
    Joaquín Borrás-Blasco
    Pharmacy Service, Hospital General Universitario de Elche, Elche, Alicante, Spain
    Ann Pharmacother 38:261-4. 2004
    ..To report a probable case of Henoch-Schönlein purpura associated with acenocoumarol therapy...
  16. ncbi request reprint Unrecognized delayed toxic lithium peak concentration in an acute poisoning with sustained release lithium product
    Joaquín Borrás-Blasco
    Pharmacy Department, Hospital de Sagunto, Avda Ramon y Cajal s n, Sagunto 46520, Valencia, Spain
    South Med J 100:321-3. 2007
    ..Therefore, patients presenting with acute intoxication with extended release formulations should be managed with caution, and continued drug monitoring is suggested...